[SUNWAY] YoY TTM Result on 31-Dec-2018 [#4]

Stock
[SUNWAY] SUNWAY BERHAD
Announcement Date
28-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- 1.31%
YoY- 3.05%
Quarter Report
Latest QR
Upcoming QR
SUNWAY's Result
SUNWAY's Financial Summary
View:
Show?
TTM Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 4,293,510 3,833,310 4,780,447 5,410,283 5,374,834 4,655,592 4,448,390 -0.58%
PBT 536,645 540,984 914,232 850,644 882,188 858,992 930,362 -8.75%
Tax 2,203,406 -101,977 -78,294 -121,637 -149,369 -140,394 -130,939 -
NP 2,740,051 439,007 835,938 729,007 732,819 718,598 799,423 22.76%
-
NP to SH 2,665,443 397,484 766,633 658,991 639,513 585,883 732,449 23.99%
-
Tax Rate -410.59% 18.85% 8.56% 14.30% 16.93% 16.34% 14.07% -
Total Cost 1,553,459 3,394,303 3,944,509 4,681,276 4,642,015 3,936,994 3,648,967 -13.25%
-
Net Worth 12,027,040 10,034,321 8,238,145 8,348,157 7,644,295 3,172,361 6,490,204 10.81%
Dividend
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div 146,669 77,187 442,280 346,191 287,537 161,325 194,835 -4.61%
Div Payout % 5.50% 19.42% 57.69% 52.53% 44.96% 27.54% 26.60% -
Equity
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 12,027,040 10,034,321 8,238,145 8,348,157 7,644,295 3,172,361 6,490,204 10.81%
NOSH 4,934,074 4,933,931 4,933,931 4,924,402 4,918,491 2,046,685 1,783,023 18.46%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 63.82% 11.45% 17.49% 13.47% 13.63% 15.44% 17.97% -
ROE 22.16% 3.96% 9.31% 7.89% 8.37% 18.47% 11.29% -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 73.18 74.49 98.65 111.47 111.80 227.47 249.49 -18.47%
EPS 45.43 7.72 15.82 13.58 13.30 28.63 41.08 1.69%
DPS 2.50 1.50 9.10 7.12 5.98 7.88 10.93 -21.78%
NAPS 2.05 1.95 1.70 1.72 1.59 1.55 3.64 -9.11%
Adjusted Per Share Value based on latest NOSH - 4,924,402
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 74.88 66.85 83.37 94.35 93.73 81.19 77.58 -0.58%
EPS 46.48 6.93 13.37 11.49 11.15 10.22 12.77 24.00%
DPS 2.56 1.35 7.71 6.04 5.01 2.81 3.40 -4.61%
NAPS 2.0975 1.7499 1.4367 1.4559 1.3331 0.5532 1.1319 10.81%
Price Multiplier on Financial Quarter End Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 1.72 1.61 1.80 1.47 1.63 3.03 3.08 -
P/RPS 2.35 2.16 1.82 1.32 1.46 1.33 1.23 11.38%
P/EPS 3.79 20.84 11.38 10.83 12.25 10.58 7.50 -10.74%
EY 26.41 4.80 8.79 9.24 8.16 9.45 13.34 12.04%
DY 1.45 0.93 5.06 4.84 3.67 2.60 3.55 -13.85%
P/NAPS 0.84 0.83 1.06 0.85 1.03 1.95 0.85 -0.19%
Price Multiplier on Announcement Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 25/02/22 31/03/21 25/02/20 28/02/19 28/02/18 28/02/17 26/02/16 -
Price 1.68 1.70 1.78 1.62 1.65 3.23 3.01 -
P/RPS 2.30 2.28 1.80 1.45 1.48 1.42 1.21 11.28%
P/EPS 3.70 22.01 11.25 11.93 12.40 11.28 7.33 -10.75%
EY 27.04 4.54 8.89 8.38 8.06 8.86 13.65 12.05%
DY 1.49 0.88 5.11 4.40 3.62 2.44 3.63 -13.78%
P/NAPS 0.82 0.87 1.05 0.94 1.04 2.08 0.83 -0.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment